Astex Pharmaceuticals Announces Expiration of HSR Waiting Period for Otsuka Tender Offer

Astex Pharmaceuticals, Inc. (Nasdaq:
ASTX
) ("Astex"), announced today that the waiting period for U.S. antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, relating to the previously announced acquisition of Astex by Otsuka Pharmaceutical Co., Ltd (OTC:
OTSKY
See full press release
Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.